Category: Health

Kenta Biotech today announced an important step towards a more efficient treatment of hospital infections: The first patient was enrolled in the phase I/II clinical trial with KBSA301, a fully human antibody for the treatment of severe pneumonia caused by Staphylococcus aureus (S. aureus). In this clinical trial, 44 patients suffering from severe pneumonia caused […]

The executive board of UNITAID today approved funding of US$ 30 million to scale up access to a new diagnostic test for tuberculosis, Xpert MTB/RIF, and reduce the cost of its use. The Xpert assay represents a major advance for the diagnosis of tuberculosis, as it is based on the recognition of the DNA of […]

Kenta Biotech verlegt ihren Firmensitz von Bern in den Bio-Technopark in Zürich-Schlieren, dem Silicon Valley der Schweizer Biotechnologie. Das im Jahr 2006 gegründete Unternehmen ist ein Spin-Off von Berna Biotech (heute Crucell Switzerland AG) und betritt neues Terrain bei der Entwicklung innovativer Behandlungsformen von Spitalinfektionen. Im neuen Zürcher Hauptsitz stehen Kenta Biotech hochmoderne Laboratorien zur […]

Kenta Biotech announced today that it is relocating from Bern to Bio-Technopark in Zurich-Schlieren, the Silicon Valley of Swiss Biotechnology. Founded in 2006 as a Berna Biotech (today Crucell Switzerland AG) spin-off, Kenta Biotech is entering a new era in its development of innovative treatment of life-threatening infections. In its new Zurich-Schlieren headquarters, Kenta Biotech […]

Kenta Biotech announced today that the European Commission has granted ‘Orphan Drug’ status to Kenta Biotech’s product KBSA301 for the treatment of severe pneumonia caused by Staphylococcus aureus (S. aureus). In addition to KBSA301, Kenta Biotech’s pipeline contains several additional compounds targeting nosocomial infections. KBSA301 is the first fully human monoclonal antibody being developed for […]

Action on Bladder Cancer (ABC) releases findings from a new National survey* exposing how little the general public knows about bladder cancer. Awareness around the main warning sign for bladder cancer – blood in the urine – is gradually increasing (50% in 2010 rising to 55% in 2012), but still only 5% of the public […]

HNA Group’s Chen Feng is designated UNITAID’s Honorary Ambassador.Mr. Chen Feng, Chairman of the HNA group, one of China’s best known enterprises, has accepted to become UNITAID’s Honorary Ambassador. Mr Chen will lend his voice and position to advocate for greater Chinese support for UNITAID’s innovative interventions to improve access to treatment for HIV, tuberculosis […]

Au deuxième jour de la conférence de l’AFRAVIH, conférence francophone internationale sur le sida à Genève, UNITAID appelle la communauté internationale à prendre trois mesures urgentes pour surmonter les obstacles entravant les progrès de la lutte contre le sida : réduire l’effet des accords de libre-échange,  puiser dans de nouvelles sources de financement, comme une […]